Thursday, July 29


BioNTech, Chile, Noticias, Pfizer, Pfizer/BioNTech, Salud, sinovac, vacunas

BioNTech offers 10 times more antibodies than Sinovac | Digital Trends Spanish

A study carried out by the University of Hong Kong reveals that those who received the Pfizer-BioNTech coronavirus vaccine have ten times more antibodies than those who were inoculated with Sinovac. The work also shows that the latter group generates levels of proteins to attack the virus that would be similar or lower than those produced naturally in patients who have recovered from COVID-19. According to the researchers, the study results, which were published in Lancet Microbe, suggest the need for "alternative strategies", such as booster vaccines, for those who have been immunized with Sinovac, as a way to increase antibody levels in these patients. "The difference in neutralizing antibody concentrations identified in our study could translate into substantial differences in the ef...